Please enable JS

Investors & Media

SEC Filings

Form 8-K
CRISPR THERAPEUTICS AG filed this Form 8-K on 01/05/2018
Document Outline
Entire Document (264 KB)
Subdocument 1 - 8-K - FORM 8-K
Page 1 - UNITED STATES
Page 2 - N/A
Page 3 - N/A
Page 4 - SIGNATURES
Subdocument 2 - EX-1.1 - EX-1.1
Page 1 - Exhibit 1.1
Page 2 - Representations and Warranties.
Page 3 - Effective Date
Page 4 - Disclosure Package
Page 5 - N/A
Page 6 - N/A
Page 7 - Material Adverse Effect
Page 8 - N/A
Page 9 - Exchange Act
Page 10 - Plan
Page 11 - Money Laundering Laws
Page 12 - Issuer Product
Page 13 - FDA
Page 14 - Purchase, Sale and Delivery of the Securities.
Page 15 - Option Exercise Date
Page 16 - Capital Increase and Initial Subscription.
Page 17 - Erh hungsbeschluss
Page 18 - Subscription and Issuance of Option Securities.
Page 19 - Zeichnungsschein
Page 20 - provided
Page 21 - Agreements.
Page 22 - N/A
Page 23 - provided
Page 24 - FINRA
Page 25 - N/A
Page 26 - N/A
Page 27 - Reimbursement of Underwriters
Page 28 - provided
Page 29 - provided
Page 30 - Losses
Page 31 - provided
Page 32 - Call Option.
Page 33 - Put Option.
Page 34 - Wertrechtebuch
Page 35 - Representations and Indemnities to Survive.
Page 36 - Authorized Agent
Page 37 - No Fiduciary Duty
Page 38 - N/A
Page 39 - N/A
Page 40 - SCHEDULE I
Page 41 - SCHEDULE II
Page 42 - SCHEDULE III
Page 43 - ANNEX A
Page 44 - SUBSCRIPTION FORM
Page 45 - N/A
Page 46 - POWER OF ATTORNEY
Page 47 - N/A
Page 48 - Aktiengesellschaft
Page 49 - Lockup Period
Page 50 - provided
Page 51 - N/A
Subdocument 3 - EX-5.1 - EX-5.1
Page 1 - Exhibit 5.1
Page 2 - N/A
Page 3 - N/A
Subdocument 4 - EX-99.1 - EX-99.1
Page 1 - Exhibit 99.1
Page 2 - Cautionary Note Regarding Forward-Looking Statements
Subdocument 5 - EX-99.2 - EX-99.2
Page 1 - Exhibit 99.2
Page 2 - Cautionary Note Regarding Forward-Looking Statements
Print Page E-mail Page RSS Feeds E-mail Alerts IR Contacts Financial Tear Sheet